Registered Trials
-
NCT04498247
Phase 1/2Austria, Belgium, United States of America
Total Enrollment: 260
Official Trial Registration:
© 2021 McGill COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.